TVM Life Science Ventures VI LP 13D/13G Filings for Albireo Pharma, Inc. (ALBO)

TVM Life Science Ventures VI LP 13D and 13G filings for Albireo Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-10-23
5:05 pm
Sale		 2019-11-06 13D Albireo Pharma, Inc.
ALBO		 TVM Life Science Ventures VI LP 0
0.000%		 -621,761decrease
(Position Closed)		 Filing